Ignite Creation Date:
2024-05-06 @ 2:15 PM
Last Modification Date:
2024-10-26 @ 1:27 PM
Study NCT ID:
NCT04262089
Status:
COMPLETED
Last Update Posted:
2023-12-05
First Post:
2020-01-28
Brief Title:
Neo-adjuvant Pembrolizumab in dMMR POLE-EDM Uterine Cancer Patients a Feasibility Study
Sponsor:
Organization:
University Medical Center Groningen